Otsuka (OTSKF) Stock Price, News & Analysis

Company Overview

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, and insecticide and toiletry products. In addition, the company offers IT solution services; adhesive tapes; flaky titanate and compounds; IV solutions; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; urinary tract health products; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. Otsuka Holdings Co., Ltd. was founded in 1921 and is headquartered in Tokyo, Japan.

Key Stats

• Today's Range: $39.48 to $39.48
• 50-Day Range: $39.48 to $39.48
• 52-Week Range: $35.91 to $41.59
• Volume: N/A
• Average Volume: 500 shs
• Market Capitalization: N/A
• P/E Ratio: 0.13
• Dividend Yield: 141.28%
• Price Target: N/A
• Consensus Rating: N/A

Otsuka Stock Analysis - MarketRank™

Otsuka scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Otsuka.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Otsuka is 0.13, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 116.61.

Price to Earnings Ratio vs. Sector

The P/E ratio of Otsuka is 0.13, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 103.07.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Otsuka has a short interest ratio ("days to cover") of 4697, which indicates bearish sentiment.

Change versus previous month

Short interest in Otsuka has recently increased by 57.56%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Otsuka pays a meaningful dividend of 3.45%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Otsuka does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Otsuka is 18.48%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Otsuka has a short interest ratio ("days to cover") of 4697, which indicates bearish sentiment.

Change versus previous month

Short interest in Otsuka has recently increased by 57.56%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 1.8 / 5
• News Sentiment: 0.16

News Sentiment

Otsuka has a news sentiment score of 0.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 9 news articles for Otsuka this week, compared to 3 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Otsuka insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 12.20% of the stock of Otsuka is held by institutions.

OTSKF Stock Analysis - Frequently Asked Questions

How have OTSKF shares performed this year?

Otsuka's stock was trading at $39.15 at the start of the year. Since then, OTSKF stock has increased by 0.8% and is now trading at $39.48.
View the best growth stocks for 2024 here.

How do I buy shares of Otsuka?

Shares of OTSKF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - General
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:OTSKF
• CUSIP: N/A
• CIK: 1544613
• Web: www.otsuka.com
• Phone: (136) 717-1410
• Fax: N/A
• Employees: 34,388
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 0.13
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A